Aer Therapeutics Closes $36 Million Series A To Advance Development Of Aer-01, An Innovative Mucolytic For The Treatment Of Lung Diseases
Amount Raised
$36 Million
Round Type
Series A
RaleighBiotechnologyInvestors
Description
Aer Therapeutics, a biopharmaceutical company developing novel inhaled treatments for muco-obstructive lung diseases, today announced the closing of a $36 million Series A financing. Funding was received from a syndicate of premier life science industry investors, including Canaan, OrbiMed, and Hatteras Venture Partners. Proceeds from the financing will be used to advance the development of AER-01, the company's novel inhaled small molecule mucolytic drug designed to liquefy mucus plugs in the lungs of patients with chronic obstructive pulmonary disease (COPD). Aer Therapeutics plans to initiate a first-in-human Phase 1 clinical trial of AER-01 in mid-2023.
Quick answer
Aer Therapeutics raised $36 Million in a Series A round, dated April 13, 2023. Investors: Aer Therapeutics, Hatteras Venture Partners, Orbi Med and Canaan. Aer Therapeutics is based in Raleigh, North Carolina, United States.
- How much did Aer Therapeutics raise?
- Aer Therapeutics raised $36 Million in a Series A round on April 13, 2023.
- Who invested in Aer Therapeutics?
- Aer Therapeutics, Hatteras Venture Partners, Orbi Med and Canaan are named as investors in this round.
- What does Aer Therapeutics do?
- Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs.
- Where is Aer Therapeutics based and how big is it?
- Aer Therapeutics is based in Raleigh, North Carolina, United States. Fundz records about 10 employees.
- Who are the decision-makers at Aer Therapeutics?
- Fundz holds 4 contacts at Aer Therapeutics, including the Associate Director, Technical Operations. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Aer Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Tangen Biosciences raised $465K (Seed) on May 26, 2023.
- Conformal Medical raised $35M on May 26, 2023.
- Qnovia raised $2.9M on May 25, 2023.
- MyndTec raised $200K on May 25, 2023.
- Renibus Therapeutics raised $64M on May 25, 2023.
- Adaptive Phage Therapeutics, Inc. raised $12M on May 25, 2023.
Who to call at Aer Therapeutics, and when
A new round usually means Aer Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aer Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aer Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aer Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aer Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAer Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.